Integrated radiogenomics models predict response to neoadjuvant chemotherapy in high grade serous ovarian cancer.
Crispin-Ortuzar M, Woitek R, Reinius MAV, Moore E, Beer L, Bura V, Rundo L, McCague C, Ursprung S, Escudero Sanchez L, Martin-Gonzalez P, Mouliere F, Chandrananda D, Morris J, Goranova T, Piskorz AM, Singh N, Sahdev A, Pintican R, Zerunian M, Rosenfeld N, Addley H, Jimenez-Linan M, Markowetz F, Sala E, Brenton JD.
Crispin-Ortuzar M, et al. Among authors: mouliere f.
Nat Commun. 2023 Oct 24;14(1):6756. doi: 10.1038/s41467-023-41820-7.
Nat Commun. 2023.
PMID: 37875466
Free PMC article.